Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retina Care 360 > Air pollution linked to higher global AMD burden
  • Retina Care 360

Air pollution linked to higher global AMD burden

Ophthalmology 360

Key Takeaways

  1. The global burden of age-related macular degeneration increased between 1990 and 2020 despite declines in age-standardized rates.
  2. Higher exposure to air pollutants, particularly PM2.5 and ozone, was associated with greater AMD prevalence worldwide.

A global analysis found that the burden of age-related macular degeneration (AMD) increased between 1990 and 2020, with air pollution emerging as a potential contributing factor to higher AMD prevalence worldwide, according to a study.

A global ecological analysis using data from the Global Burden of Disease study evaluated national-level associations between AMD burden and environmental and lifestyle factors, including ambient air pollutants, household air pollution from solid fuel use, and smoking prevalence. Outcomes included disability-adjusted life years (DALYs), age-standardized DALYs, and age-standardized AMD prevalence from 1990 to 2020.

Although age-standardized DALYs and age-standardized AMD prevalence declined by 19.2% and 3.4%, respectively, significant correlations were identified between AMD prevalence and several pollution measures in 2020. Age-standardized AMD prevalence was positively correlated with particulate matter ≤ 2.5 μm (P < 0.001), ozone (P < 0.001), and household air pollution (P < 0.001). Smoking prevalence showed a significant negative correlation with AMD prevalence (P < 0.001).

In multivariable regression analyses, particulate matter ≤ 2.5 μm and ozone emerged as independent predictors of AMD prevalence, with odds ratios of 8.09 and 5.42, respectively (both P < 0.001).

Reference

Mimura T, Nishijima Y, Hasegawa D, et al. Global association between ambient air pollution and age-related macular degeneration: an ecological analysis across 203 countries. Environ Sci Pollut Res Int. 2026;doi: 10.1007/s11356-026-37869-8. Epub ahead of print. PMID: 42201532.

Share

Related Content

  • Retina Care 360

Cooling anesthesia device reduces pain during intravitreal injections

  • Retina Care 360

Physical activity shows mixed effects on visual outcomes in type 2 diabetes

  • Retina Care 360

Google searches for retinal detachment rose markedly in the United States

  • Retina Care 360

Quiz: Mental health risks linked to age-related eye disease

  • Retina Care 360

Cost analysis shows greater losses for pediatric versus adult retinal detachment repairs

  • Retina Care 360

Phase 3 SOL-1 trial results are a “landmark achievement” for investigational TKI therapy for wet AMD

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon